Atossa Genetics Conference Call and Webcast Notice
SEATTLE, WA, Oct 04, 2013 (Marketwired via COMTEX) --
Atossa Genetics Inc. (NASDAQ: ATOS), The Breast Health Company(TM),
will host a conference call at 5:45 pm Eastern Time today to discuss
the Company's voluntary recall of its ForeCYTE Breast Health Test;
Mammary Aspiration Specimen Cytology Test (MASCT) System, which was
announced today at 5:00 pm Eastern Time.
To listen to the call by phone, interested parties within the U.S.
may dial 866-652-5200. International callers should dial
412-317-6060. All callers should ask for the Atossa Genetics
conference call. The conference call will also be available through a
live webcast at
A replay of the call will be available one hour after the end of the
call through November 4, 2013, and can be accessed via Atossa's
website or by dialing 877-344-7529 (domestic) or 412-317-0088
(international). The replay conference ID number is 10034877.
About Atossa Genetics, Inc.
Atossa Genetics, Inc. is focused on the commercialization of
patented, diagnostic medical devices and, through its wholly-owned
subsidiary, The National Reference Laboratory for Breast Health, Inc.
(NRLBH), patented, laboratory developed tests designed to assess
The NRLBH is a CLIA-certified high-complexity molecular diagnostic
laboratory located in Seattle, Washington.
For additional information, on Atossa and the NRLBH, please visit
www.atossagenetics.com and www.nrlbh.com.
Atossa Genetics, Inc.
CFO and General Counsel
MBS Value Partners
Matthew D. Haines (Investors)
Jules Abraham (Media)
SOURCE: Atossa Genetics, Inc.
[ Back To Technology News's Homepage ]